Using heart biomarker levels to guide therapy does not improve outcomes for heart failure patients
Wednesday, January 28, 2009 - 14:07
in Health & Medicine
Using a measure of the hormone N-terminal brain natriuretic peptide (BNP) to guide therapy for older patients with heart failure did not improve overall clinical or quality of life outcomes compared to patients receiving conventional symptom-guided therapy, according to a study in the 28 January issue of JAMA...
Read the whole article on Science Centric
More from Science Centric
Related
- Using heart biomarker levels to guide therapy does not improve outcomes for heart failure patientsTue, 27 Jan 2009, 16:22:25 EST
- Biomarkers as a guide to therapy in heart failure patientsTue, 27 Jan 2009, 16:22:18 EST
- Exercise is safe, improves quality of life in patients with chronic heart failureTue, 7 Apr 2009, 17:22:49 EDT
- Exercise plus psychological counseling may benefit depressed heart failure patientsFri, 2 May 2008, 16:35:14 EDT
- Recommended treatment for heart failure often underusedTue, 20 Oct 2009, 16:32:05 EDT